Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China

AIDS Research and Human Retroviruses

Volumn 27, Issue 8, 2011, Pages 925-930

  Liu, Jia ^a   Chen, Xiangmei ^a   Xie, Qing ^a   Zhang, Weidong ^b   Wei, Lai ^c   Shen, Tao ^a   Xu, Qiang ^a   Zhuang, Hui ^a   Gao, Feng ^a,d   Lu, Fengmin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOODSTREAM INFECTION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHINA; CROSS-SECTIONAL STUDY; DISEASE COURSE; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PATIENT COMPLIANCE; PHYLOGENETIC TREE CONSTRUCTION METHOD; PRIORITY JOURNAL; RNA VIRUS; SEQUENCE ANALYSIS; STRUCTURAL GENE; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOOD DONORS; CD4 LYMPHOCYTE COUNT; CHINA; DISEASE PROGRESSION; DRUG RESISTANCE, VIRAL; FEMALE; GENES, POL; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; PATIENT COMPLIANCE; PHYLOGENY; PREVALENCE; REVERSE TRANSCRIPTASE INHIBITORS; RNA-DIRECTED DNA POLYMERASE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 80051484046     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0328     Document Type: Article

References (20)

1. Wu Z, Liu Z, and Detels R: HIV-1 infection in commercial plasma donors in China. Lancet 1995;346(8966):61-62.
2. Wu Z, Rou K, and Detels R: Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Planning 2001;16(1):41-46. (Pubitemid 32183647)
3. Zhang F, Haberer JE, Wang Y, et al.: The Chinese free antiretroviral treatment program: Challenges and responses. AIDS 2007;21(Suppl 8):S143-148.
4. Zhang FJ, Pan J, Yu L, Wen Y, and Zhao Y: Current progress of China's free ART program. Cell Res 2005;15(11-12): 877-882. (Pubitemid 41826254)
5. Zhang F, Dou Z, Ma Y, et al.: Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med 2009;151(4):241-251, W-252.
6. Zhang M, Han XX, Cui WG, et al.: The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation. Jpn J Infect Dis 2008;61(5):361-365.
7. Zhang L, Chen Z, Cao Y, et al.: Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china. J Virol 2004;78(24):13591-13599. (Pubitemid 39612759)
8. Liu P, Xiang K, Tang H, et al.: Molecular epidemiology of human immunodeficiency virus type 1 and hepatitis C virus in former blood donors in central China. AIDS Res Hum Retroviruses 2008;24(1):1-6.
9. Su B, Liu L, Wang F, et al.: HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS 2003;17(17):2515-2520. (Pubitemid 38393325)
10. Soto B, Sanchez-Quijano A, Rodrigo L, et al.: Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26(1):1-5. (Pubitemid 27072597)
11. Thomas DL, Astemborski J, Rai RM, et al.: The natural history of hepatitis C virus infection: Host, viral, and environmental factors. JAMA 2000;284(4):450-456. (Pubitemid 30484478)
12. McGovern BH: Hepatitis C in the HIV-infected patient. J Acquir Immune Defic Syndr 2007;45(Suppl 2):S47-56; discussion S66-67. (Pubitemid 47294916)
13. Andersson K and Chung RT: Hepatitis C Virus in the HIVinfected patient. Clin Liver Dis 2006;10(2):303-320, viii.
14. Qian HZ, Vermund SH, Kaslow RA, et al.: Co-infection with HIV and hepatitis C virus in former plasma/blood donors: Challenge for patient care in rural China. AIDS 2006;20(10): 1429-1435. (Pubitemid 43948250)
15. Xu JQ, Wang JJ, Han LF, et al.: Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, China. Chin Med J 2006;119(23):1941- 1948.
16. Pan PL, Liu Z, Zhang YH, et al.: Study on the influence of biological characteristics to HIV/HCV co-infection among HIV infected illegal blood donors in China. Zhonghua Liu Xing Bing Xue Za Zhi 2007;28(6):589-592.
17. Liu Z, Xing WG, Zhang YH, et al.: Study on the epidemiology and HCV genotype distribution of HIV/HCV coinfection among HIV infected blood donors in China. Zhonghua Gan Zang Bing Za Zhi 2006;14(6):464-465.
18. Li JY, Li HP, Li L, et al.: Prevalence and evolution of drug resistance HIV-1 variants in Henan, China. Cell Res 2005;15(11-12):843-849. (Pubitemid 41826249)
19. Jiang S, Xing H, Si X, Wang Y, and Shao Y: Polymorphism of the protease and reverse transcriptase and drug resistance mutation patterns of HIV-1 subtype B prevailing in China. J Acquir Immune Defic Syndr 2006;42(4):512-514. (Pubitemid 44050904)
20. Yoo TW, Donfield S, Lail A, Lynn HS, and Daar ES: Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis 2005;191(1):4-10. (Pubitemid 40041393)